PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 79 filers reported holding PROGENICS PHARMACEUTICALS IN in Q2 2013. The put-call ratio across all filers is 44.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $275,000 | -58.6% | 36,800 | -66.9% | 0.01% | -64.3% |
| Q1 2015 | $664,000 | -23.1% | 111,100 | -2.7% | 0.01% | -30.0% |
| Q4 2014 | $864,000 | +45.7% | 114,232 | 0.0% | 0.02% | +33.3% |
| Q3 2014 | $593,000 | +20.5% | 114,232 | 0.0% | 0.02% | +15.4% |
| Q2 2014 | $492,000 | +59.2% | 114,232 | +51.2% | 0.01% | +44.4% |
| Q1 2014 | $309,000 | -19.9% | 75,532 | +4.3% | 0.01% | -25.0% |
| Q4 2013 | $386,000 | +6.3% | 72,400 | 0.0% | 0.01% | 0.0% |
| Q3 2013 | $363,000 | +12.4% | 72,400 | 0.0% | 0.01% | -7.7% |
| Q2 2013 | $323,000 | – | 72,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|